PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CRDMO with a focus on innovative chemistry and low-carbon manufacturing, is proud to announce that it has been awarded the 2024 CMO Excellence in Green Chemistry Award by the American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCI PR). This esteemed award, marking the company’s second consecutive win among global CDMO companies, is a testament to PharmaBlock’s persistent commitment to green chemistry and its unwavering efforts in crafting innovative, sustainable solutions for the pharmaceutical industry.